Prostate Cancer - Results from #23400

Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: Results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study - Abstract April 18, 2013

Salvage high-intensity focused ultrasound ablation for prostate cancer local recurrence after external-beam radiation therapy: Prognostic value of prostate MRI - Abstract April 18, 2013

Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer - Abstract April 18, 2013

Permanent implant prostate cancer brachytherapy: 2013 State-of-the art - Abstract April 18, 2013

The role of MRI in active surveillance of prostate cancer - Abstract April 18, 2013

Prostate cancer mortality in the Finnish randomized screening trial - Abstract April 18, 2013

Counterpoint: Randomized trials provide the strongest evidence for clinical guidelines: The US Preventive Services Task Force and Prostate Cancer Screening - Abstract April 18, 2013

Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: Are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? - Abstract April 18, 2013

Proton beam therapy and localised prostate cancer: Current status and controversies - Abstract April 17, 2013

High resolution ultrasound features of prostatic rib metastasis: A prospective feasibility study with implication in the high-risk prostate cancer patient - Abstract April 17, 2013

Effect of metabolic syndrome and its components on prostate cancer risk: Meta-analysis - Abstract April 17, 2013

Prostate implant dosimetric outcomes and migration patterns between bio-absorbable coated and uncoated brachytherapy seeds - Abstract April 17, 2013

Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-Year outcomes - Abstract April 17, 2013

Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer - Abstract April 17, 2013

Impact of the radiotherapy technique on the correlation between dose-volume histograms of the bladder wall defined on MRI imaging and dose-volume/surface histograms in prostate cancer patients - Abstract April 17, 2013

Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent - Abstract April 17, 2013

Prostate cancer and androgen deprivation: Benefits of psychological counseling - Abstract April 16, 2013

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials - Abstract April 16, 2013

A randomized trial comparing seed displacement of coated seeds to regular loose seeds at 30 days postimplant - Abstract April 16, 2013

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression - Abstract April 16, 2013

Page 1171 of 1435